Black Diamond Therapeutic (NASDAQ:BDTX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Black Diamond Therapeutic (BDTX) operate in?

Black Diamond Therapeutic is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Black Diamond Therapeutic Stock (NASDAQ: BDTX) stock price, news, charts, stock research, profile.

Open	$2.19
Close	$2.24
Volume / Avg.	531.02K / 747.59K
Day Range	$2.10 - $2.26
52 Wk Range	1.91 - 7.66
Market Cap	$125.62M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	18.92%
Days to Cover	13.47

Recent News

Why Sage Therapeutics Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor Activity In Certain Type Of Lung Cancer Resistant To AstraZeneca's Drug

Black Diamond Therapeutics reports promising initial Phase 2 data for BDTX-1535 in relapsed EGFR-mutant NSCLC patients. With a 36% objective response rate and encouraging durability, BDTX-1535 shows potential to address osimertinib resistance.

Vandana Singh

Black Diamond Therapeutics And 2 Other Stocks Under $3 Insiders Are Buying

The Dow Jones closed lower by around 250 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul 24

Aug 24

Sep 24

Oct 24

Nov 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.19
Close	$2.24
Volume / Avg.	531.02K / 747.59K
Day Range	$2.10 - $2.26
52 Wk Range	1.91 - 7.66
Market Cap	$125.62M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	18.92%
Days to Cover	13.47

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Black Diamond Therapeutic (BDTX) stock?

You can purchase shares of Black Diamond Therapeutic (NASDAQ:BDTX) through any online brokerage.

View our list of the best stock brokerages

Who are Black Diamond Therapeutic (BDTX) competitors?

Other companies in Black Diamond Therapeutic’s space includes: Zura Bio (NASDAQ:ZURA), Renovaro (NASDAQ:RENB), Invizyne Technologies (NASDAQ:IZTC), Innate Pharma (NASDAQ:IPHA) and Cabaletta Bio (NASDAQ:CABA).

What is the forecast, or price target, for Black Diamond Therapeutic (BDTX) stock?

Black Diamond Therapeutic has a consensus price target of $14.40.

What is the current price for Black Diamond Therapeutic (BDTX)?

The stock price for Black Diamond Therapeutic (NASDAQ: BDTX) is $2.22 last updated January 21, 2025 at 7:06 PM EST.

Does Black Diamond Therapeutic (BDTX) pay a dividend?

There are no upcoming dividends for Black Diamond Therapeutic.

When is Black Diamond Therapeutic (NASDAQ:BDTX) reporting earnings?

Black Diamond Therapeutic’s Q4 earnings are confirmed for Tuesday, March 11, 2025.

Is Black Diamond Therapeutic (BDTX) going to split?

There is no upcoming split for Black Diamond Therapeutic.

What sector and industry does Black Diamond Therapeutic (BDTX) operate in?

Black Diamond Therapeutic is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Black Diamond Therapeutic

Black Diamond Therapeutic (BDTX) Forecast